Health Care

Eleven nursing homes in Central Massachusetts received the top rating in U.S. News & World Report's annual list of best nursing homes.

Privacy has been an obligation of the medical profession dating back to the ancient Greeks and the Hippocratic Oath. However, safeguarding patient information has transformed alongside an industry that increasingly relies on technology.

Electronic health records have rolled out in force over the last several years. And, hundreds of companies offer software, and government has provided incentives and mandates for medical offices to modernize. Many patients are logging on to perform tasks that once took a phone call or visit.

Sunovion Pharmaceuticals of Marlborough announced the start of a phase 3 clinical trial program for SUN-101, an inhalation solution being investigated for the treatment of chronic obstructive pulmonary disease (COPD).

Registered nurses at Saint Vincent Hospital have ratified a new three-year contract with the Worcester health-care facility, ending more than a year of contract talks, the nurses' union announced Monday morning.

One thing I've learned from covering the local health care industry is that MetroWest-area companies are making...

Talk to technology entrepreneurs and there's a question that often comes up: Would you rather do cool stuff or important stuff? Make an amazing virtual reality headset or improve the treatment options for diabetes? ReWalk Robotics doesn't have to choose.

Bing Yeo has years of experience owning and running franchises, and helping other business owners run their companies more effectively. He also isn't afraid to try new things.

UMass Medical School in Worcester will collaborate with Lysogene, a French biotechnology company, and Auburn University in Alabama, to develop pre-clinical studies of a rare disorder that causes neurological impairment, Lysogene announced.

Preeclampsia is a leading cause of maternal and infant death worldwide, though the causes are poorly understood, and treatment options are limited. When an expectant mother develops the disease – which causes high blood pressure, swelling, headache, vision changes and seizures – the normal course of action is to deliver the baby as soon as possible to avoid the potential death of both mother and baby. But when it occurs too early in a pregnancy, that remedy is surrounded by health risks for the baby that could result in life-long problems. It's a conundrum rEVO Biologics of Framingham is trying to solve. The biopharmaceutical company, which is focused on developing and commercializing treatments for patients with rare, life-threatening diseases, began clinical trials last summer on a drug that may allow women to prolong their pregnancies than what available medicine allows.